Advertisement Avid Radiopharmaceuticals names new CFO - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Avid Radiopharmaceuticals names new CFO

Avid Radiopharmaceuticals, which provides products for detection, diagnosis and monitoring of brain disorders, has appointed Richard Baron as its new CFO.

Mr Baron brings more than 20 years of financial experience to Avid, most recently serving as the CFO of eResearchTechnology, a publicly traded, technology-based, clinical research organization.

Daniel Skovronsky, president and CEO of Avid, said: “Rick’s accomplishments and experience as a CFO and senior manager of several public companies are critical for us as we grow our company in preparation for the Phase III development and eventual commercialization of our products.”